Publications by authors named "Samir Lababidi"

Claim this Profile
T
The impact of misclassification errors on the performance of biomarkers based on next-generation sequencing, a simulation study.
Dong Wang, Sue-Jane Wang, Samir Lababidi

J Biopharm Stat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards accurate indel calling for oncopanel sequencing through an international pipeline competition at precisionFDA.
Binsheng Gong, Samir Lababidi, Rebecca Kusko, Khaled Bouri, Sarah Prezek

Sci Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extend the benchmarking indel set by manual review using the individual cell line sequencing data from the Sequencing Quality Control 2 (SEQC2) project.
Binsheng Gong, Dan Li, Yifan Zhang, Rebecca Kusko, Samir Lababidi

Sci Rep· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
US FDA public meeting: identification of concepts and terminology for multicomponent biomarkers.
Abena S Agyeman, Abbas Bandukwala, Khaled Bouri, Jessica Hawes, Daniel M Krainak, Samir Lababidi

Biomark Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A targeted simulation-extrapolation method for evaluating biomarkers based on new technologies in precision medicine.
Dong Wang, Sue-Jane Wang, Joshua Xu, Samir Lababidi

Pharm Stat· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing reproducibility of inherited variants detected with short-read whole genome sequencing.
Bohu Pan, Luyao Ren, Vitor Onuchic, Meijian Guan, Rebecca Kusko, Samir Lababidi

Genome Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.
Wenming Xiao, Luyao Ren, Zhong Chen, Li Tai Fang, Yongmei Zhao, Samir Lababidi

Nat Biotechnol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Best practices for benchmarking germline small-variant calls in human genomes.
Peter Krusche, Len Trigg, Paul C Boutros, Christopher E Mason, Francisco M De La Vega, Samir Lababidi

Nat Biotechnol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Best practices for benchmarking germline small-variant calls in human genomes.
Peter Krusche, Len Trigg, Paul C Boutros, Christopher E Mason, Francisco M De La Vega, Samir Lababidi

Nat Biotechnol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall conceptual framework for studying the genetics of autoimmune diseases following vaccination: a regulatory perspective.
Samir Lababidi, Andrea Sutherland, Barbara Krasnicka, Richard A Forshee, Steven A Anderson

Biomark Med· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, characterization, and targeting of IL-4 receptor by IL-4-Pseudomonas exotoxin in mouse models of anaplastic thyroid cancer.
Bharat H Joshi, Akiko Suzuki, Toshio Fujisawa, Pamela Leland, Frederick Varrichio, Samir Lababidi

Discov Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of RNA-seq and microarray-based models for clinical endpoint prediction.
Wenqian Zhang, Ying Yu, Falk Hertwig, Jean Thierry-Mieg, Wenwei Zhang, Samir Lababidi

Genome Biol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the disease.
Bharat H Joshi, Pamela Leland, Samir Lababidi, Frederick Varrichio, Raj K Puri

Cancer Med· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases.
Peter B McGarvey, Baris E Suzek, James N Baraniuk, Shruti Rao, Brian Conkright, Samir Lababidi

BMC Immunol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene markers of cellular aging in human multipotent stromal cells in culture.
Ian H Bellayr, Jennifer G Catalano, Samir Lababidi, Amy X Yang, Jessica L Lo Surdo

Stem Cell Res Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.
Leming Shi, Gregory Campbell, Wendell D Jones, Fabien Campagne, Zhining Wen, Samir Lababidi

Nat Biotechnol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting angiogenesis via a c-Myc/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma.
Jing Zhang, Martin Sattler, Giovanni Tonon, Clemens Grabher, Samir Lababidi

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosomal instability is associated with higher expression of genes implicated in epithelial-mesenchymal transition, cancer invasiveness, and metastasis and with lower expression of genes involved in cell cycle checkpoints, DNA repair, and chromatin maintenance.
Anna V Roschke, Oleg K Glebov, Samir Lababidi, Kristen S Gehlhaus, John N Weinstein

Neoplasia· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in DNA microarray studies from the regulatory perspective.
Samir Lababidi

J Biopharm Stat· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells.
William C Reinhold, Mark A Reimers, Alika K Maunakea, Sohyoung Kim, Samir Lababidi

Mol Cancer Ther· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Women participating in a dietary intervention trial maintain dietary changes without much effect on household members.
Katherine Radakovich, Lance K Heilbrun, Raghu Venkatranamamoorthy, Samir Lababidi, David M Klurfeld

Nutr Cancer· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel.
Kimberly J Bussey, Koei Chin, Samir Lababidi, Mark Reimers, William C Reinhold

Mol Cancer Ther· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Karyotypic "state" as a potential determinant for anticancer drug discovery.
Anna V Roschke, Samir Lababidi, Giovanni Tonon, Kristen S Gehlhaus, Kimberly Bussey

Proc Natl Acad Sci U S A· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levels of 5-hydroxymethyl-2'-deoxyuridine in DNA from women participating in an intervention trial of low-fat and low-energy diets.
Zora Djuric, Samir Lababidi, Virginia E Uhley, Lance K Heilbrun

Biomarkers· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.
Gergely Szakács, Jean-Philippe Annereau, Samir Lababidi, Uma Shankavaram, Angela Arciello

Cancer Cell· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis